NIH Common Fund's
Stimulating Peripheral Activity to Relieve Conditions (SPARC) Program
New at Experimental Biology 2020! SPARC
is bridging the gap to make precision neuromodulation therapies a reality.
What is the SPARC program?
The NIH Common Fund's Stimulating Peripheral Activity to Relieve Conditions (SPARC) program is creating maps, tools, and technologies to advance bioelectronic medicine—the use of therapeutic devices that precisely modulate electrical activity in nerves to improve organ function.
SPARC is providing a scientific and technological foundation for future bioelectronic medicine devices and applications across a range of organs and tissues, including lung, bladder, colon, stomach, and heart.
SPARC data is freely available through an open-source SPARC Portal
where researchers can explore data, view maps, and run predictive simulations.
Learn more at the SPARC research talks and posters, experience what the SPARC Portal can do for you at the SPARC Portal: Data Resource Center Hands-On
event and discover the latest advances and opportunities for collaboration at the SPARC Tools & Technologies Showcase
Common Fund Metabolomics Consortium: Advances in Untargeted Metabolomics and Compound Identification and Implications for Biomedical Research
Overview of Subject-Matter
Untargeted metabolomics has enormous potential for advancing biomedical research and holds unprecedented promise for the community. An important aspect of untargeted metabolomics is the identification of unknown biologically relevant molecules, and that is the main thrust of the new NIH Common Fund Metabolomics Consortium. This session will provide an overview of the newly funded CF-Metabolomics Consortium and its resources, as well as discussions on advances in unknown metabolite identification, the role of untargeted metabolomics in biomedical research, and the potential for incorporating metabolomics datasets from biomedical studies into the National Metabolomics Data Repository.
This will be a 120-minute oral session with 4 speakers, each speaking for 30 minutes; it will open with brief introductory comments. Speakers will strive to make their presentations audience-friendly, geared towards the biomedical community. Attendees of this session will learn about various strategies employed in metabolite identification, the impact of untargeted metabolomics on biomedical research with examples, along with info about consortium resources.
Tentative Speakers and Session Titles
Richard Yost (University of Florida)
– “The NIH Common Fund Metabolomics Initiative: Driving Biomedical Research”
Oliver Fiehn (UC-Davis
) – “Revolutionizing the Search for Determinants of Disease by Identifying Biochemically Novel Metabolites”
Shankar Subramaniam and Eoin Fahy (UC-San Diego
) – “The National Metabolomics Data Repository and Biomedical Research”
Gary Patti (Washington University)
– “Innovations towards Annotating the Metabolome”
Alexey Nesvizhskii or Alla Karnovsky (University of Michigan)
– “Cutting-edge Analytical Technologies to Identify Unknown Metabolites in Biomedical Research”